Changes in serotype prevalence and antimicrobial resistance among invasive Streptococcus pneumoniae isolates in Korea, 1996-2008

Journal of Medical Microbiology

Volumn 62, Issue PART8, 2013, Pages 1204-1210

  Lee, Sungkyoung ^a   Bae, Songmee ^a   Lee, Kwang Jun ^a   Yu, Jae Yon ^a   Kang, Yeonho ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CEREBROSPINAL FLUID; CHILD; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; PLEURA FLUID; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PRIVATE HOSPITAL; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PREVALENCE; REPUBLIC OF KOREA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84880287500     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.058164-0     Document Type: Article

References (21)

1. Chen, Y. Y., Yao, S. M., Chou, C. Y., Chang, Y. C., Shen, P. W., Huang, C. T., Su, H. P. & Li, S. Y. (2006). Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003. J Med Microbiol 55, 1109-1114.
2. Choi, E. H., Kim, S. H., Eun, B. W., Kim, S. J., Kim, N. H., Lee, J. & Lee, H. J. (2008). Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 14, 275-281.
3. CLSI. (2008). Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
4. Dagan, R. (2009). Serotype replacement in perspective. Vaccine 27 (Suppl 3), C22-C24.
5. Dagan, R. & Klugman, K. P. (2008). Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8, 785-795.
6. Eun, B. W., Kim, S. J., Cho, E. Y., Lee, J., Choi, E. H. & Lee, H. J. (2010). Genetic structure of Streptococcus pneumoniae isolated from children in a tertiary care university hospital, in Korea, 1995 to 2005. Diagn Microbiol Infect Dis 68, 345-351.
7. Hausdorff, W. P., Feikin, D. R. & Klugman, K. P. (2005). Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5, 83-93.
8. Hicks, L. A., Harrison, L. H., Flannery, B., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D., Thomas, A., Beall, B. & other authors (2007). Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196, 1346-1354.
9. Imöhl, M., Reinert, R. R., Ocklenburg, C. & van der Linden, M. (2010). Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. J Clin Microbiol 48, 1291-1296.
10. Isozumi, R., Ito, Y., Ishida, T., Hirai, T., Ito, I., Maniwa, K., Hayashi, M., Kagioka, H., Hirabayashi, M. & other authors (2008). Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan. J Infect Chemother 14, 258-261.
11. Jacobs, M. R., Bajaksouzian, S., Bonomo, R. A., Good, C. E., Windau, A. R., Hujer, A. M., Massire, C., Melton, R., Blyn, L. B. & other authors (2009). Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype. J Clin Microbiol 47, 64-72.
12. Jefferies, J. M., Smith, A. J., Edwards, G. F., McMenamin, J., Mitchell, T. J. & Clarke, S. C. (2010). Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol 48, 87-96.
13. Lee, S., Lee, K., Kang, Y. & Bae, S. (2010). Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. Microb Drug Resist 16, 135-142.
14. Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G., Beall, B. & Active Bacterial Core Surveillance Team (2005). Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 192, 1988-1995.
15. Park, I. H., Park, S., Hollingshead, S. K. & Nahm, M. H. (2007). Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 75, 4482-4489.
16. Pichichero, M. E. & Casey, J. R. (2007). Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298, 1772-1778.
17. Pillai, D. R., Shahinas, D., Buzina, A., Pollock, R. A., Lau, R., Khairnar, K., Wong, A., Farrell, D. J., Green, K. & other authors (2009). Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 10, 642-654.
18. Stephens, D. S., Zughaier, S. M., Whitney, C. G., Baughman, W. S., Barker, L., Gay, K., Jackson, D., Orenstein, W. A., Arnold, K. & other authors (2005). Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365, 855-863.
19. Talbot, T. R., Poehling, K. A., Hartert, T. V., Arbogast, P. G., Halasa, N. B., Mitchel, E., Schaffner, W., Craig, A. S., Edwards, K. M. & Griffin, M. R. (2004). Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39, 641-648.
20. van Gils, E. J., Veenhoven, R. H., Hak, E., Rodenburg, G. D., Keijzers, W. C., Bogaert, D., Trzcinski, K., Bruin, J. P., van Alphen, L. & other authors (2010). Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA 304, 1099-1106.
21. Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T. & other authors (2003). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348, 1737-1746.